Aries Biotech wants to hear from you!
Are you interested in #biomarkers and #therapeutics for #neurologicaldisease and #brainhealth? Aries Biotech want to hear from you! Your...
top of page
Search
Thank you, CSIRO!
Aries Biotech extends gratitude to CSIRO, Australia's national science agency, for inviting Dr. Angela Boutte, the founder of Aries...
16 views0 comments
Aries Biotech - New Services!
Revolutionizing Neuroscience and Neurotrauma: Aries Biotech Announces New Services Available to KOLs and Investors...
11 views0 comments
Now Available as an E-Book!
Amyloid Beta Peptides as Biomarkers of Subconcussion Aries Biotech is pleased to share that a recent publication is now available within...
8 views0 comments
Aries Biotech Consults for Montine Lab at Stanford University
Neurological Disease and Dementia Strategies Aries Biotech and the Montine Lab, at Stanford University, are merging their expertise in...
10 views0 comments
Thank you, University of Alabama!
Honored to serve as a guest speaker for the Neuroscience Roadmap Scholars Program within the Department of Neurobiology, University of...
9 views0 comments
Aries Biotech is Expanding!
Aries Biotech is pleased to announce new hours of operation! Effective 01 October 2022, hours of operation will be Monday-Thursday, 8am...
16 views0 comments
The Potential Role of Amyloid Beta Peptides Concussion Biomarkers Reported
Increased levels of circulating amyloid beta (abeta) - 40 and -42 peptides are often increased after concussion. As such, these peptides...
16 views0 comments
Aries Biotech Consults for Neurovations, Napa, CA
Biomarkers for Neurological Disease and Dementia Aries Biotech and Neurovations are merging their expertise in research and development...
30 views0 comments
Frontiers Topic Open for Submissions - Enzymes in Brain Trauma and Disease
Frontiers is the 3rd most-cited research publisher and reports groundbreaking discoveries by the world's top experts. Frontiers,...
22 views0 comments
Thank you, University of St. Andrews!
Honored to serve as a guest speaker for the event “Do You Want To Be A Neuroscientist?” hosted by the Careers Centre and the School of...
26 views0 comments
Happy New Year from Aries Biotech!
We look forward to continuing to provide you with consultation services. More great things to come in 2022! To learn how we can assist...
16 views0 comments
Aries Biotech Partners with NeuroTheranostics, Inc.
Peptide-based Strategies for Healing Neurological Damage Aries Biotech and NeuroTheranostics are merging their collective expertise in...
23 views0 comments
Neurotrauma Biomarker Research Featured in Reuters Health Medical News!
“Elevated serum neurotrauma biomarkers seen with low-level occupational blast exposure” To learn how our expertise in brain biomarkers...
30 views0 comments
Neurotrauma Biomarkers Evident after Blast Exposure without TBI Diagnosis
Service members and law enforcement personnel are routinely exposed to blast overpressure, a harmful displacement of air from explosives...
58 views0 comments
Measuring Blood Biomarkers with Greater Sensitivity - Cathepsin B Assay Developed
An ultrasensitive biomarker assay for cathepsin B measurement in blood has been developed as a research tool. Cathepsin B is a lysosomal...
17 views0 comments
Brain-Related Proteins in Blood Reveal the Effects of Blast Exposure
Blast overpressure is a displacement of air above normal levels generated by heavy caliber weapons or from explosives. Service Members...
11 views0 comments
Brain Trauma Borrows from Alzheimer’s Disease to Degrade the Brain
Featured in EurekAlert, AAAS Traumatic brain injury (TBI) is a risk factor for Alzheimer’s disease (AD) and other dementias. Pieces of...
25 views0 comments
Aries Biotech Partners with Seventh Dimension
Improving Outcomes and Removing Diagnostic Barriers for Brain Injury Aries Biotech and Seventh Dimension, LLC are merging their expertise...
36 views0 comments
Long-studied protein could be a measure of traumatic brain injury
https://www.liebertpub.com/doi/abs/10.1089/neu.2019.6537
24 views0 comments
bottom of page